Yahoo Web Search

  1. Ads
    related to fda
  1. Much of it is because of low immunization rates as a result of vaccine misinformation, according to many medical experts. “I think vaccines are honestly a victim of their own success,” Dr. Paul ...

  2. DexCom's (DXCM) New G6 Pro CGM System Gets FDA Approval

    Zacks via Yahoo FinanceOct 09 14:31 PM

    DXCM announced that the FDA has approved its G6 Pro Continuous Glucose Monitoring (“CGM”) System for use on patients (aged two years and up). This further fortifies DexCom's foothold ...

  3. Australian Drug Maker Jumps 51% After Winning FDA Approval

    Bloomberg via Yahoo FinanceOct 09 4:12 AM

    Scenesse is the first FDA-approved treatment to help erythropoietic protoporphyria patients increase their exposure to light, the agency said.

  4. Johnson & Johnson (NYSE: JNJ) reported third-quarter earnings of $2.12 per share on Tuesday, beating the $2 Street estimate. The company's quarterly sales of $20.73 billion beat the analyst ...

  5. This August, the FDA accepted the new drug application (NDA) for avapritinib to treat patients with PDGFRA Exon 18 mutant gastrointestinal stromal tumors (GIST), regardless of any prior ...

  6. Roche Announces Positive Late-Stage Data on Rituxan in PV

    Zacks via Yahoo FinanceOct 14 13:28 PM

    We note that Rituxan became the first biologic therapy for PV after being approved by the FDA in June 2018 and the European Commission in March 2019. The phase III study was designed ...

  7. Here's Why You Should Hold on to Teleflex (TFX) Stock Now

    Zacks via Yahoo FinanceOct 09 11:50 AM

    This marks a major step toward attaining FDA approval.

  8. Biotech stocks that hit 52-week lows Oct. 8. ABIOMED, Inc. NASDAQ: ABMD) Adamas Pharmaceuticals Inc (NASDAQ: ADMS) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP) AEterna Zentaris Inc.

  9. Natera Inc (NASDAQ: NTRA) Ra Pharmaceuticals Inc (NASDAQ: RARX) Reata Pharmaceuticals Inc (NASDAQ: RETA) (Biotech stocks that hit 52-week lows on Oct. 14. Adaptive Biotechnologies Corp (NASDAQ ...

  10. Regulatory Go-Aheads: Market is upbeat about Edwards Lifesciences' receipt of FDA approval in August 2019 for expanding the use of its flagship SAPIEN 3 and SAPIEN 3 Ultra transcatheter ...

  1. Ads
    related to fda